Last Updated on October 15, 2024 by The Health Master
Amravati: Drug maker Hetero Group will be investing Rs 1,000 crore to expand its pharmaceutical and specialist business in Andhra Pradesh, its Managaing Director Vamsi Krishna Bandi said.
Speaking at Global Investors Summit 2023 here, he said post-Covid pandemic, more countries are looking at India as a partner of choice in pharmaceutical sector, and Andhra Pradesh is ideally placed to take advantage because of a well-established ecosystem.
“We are committed to Andhra Pradesh and will continue to expand our presence here.”
“We’ll be investing about Rs 1,000 crore in Andhra Pradesh over the next two years to grow our pharmaceutical and specialty business.”
“This will generate an employment of a minimum of 3,000 people,” he said.
Bandi further said the USD 2.5 billion pharma group employs over 10,000 people directly and indirectly in Andhra Pradesh, and supplies about 40 per cent of global HIV medicines that are manufactured in the state.
IMA warning: Antibiotics for seasonal cold, cough will not work due to this reason
USFDA gives approval for Vigabatrin for Oral Solution
Drug recall: Artificial Tears Lubricant Eye Drops recalled due to this reason
FDA issues show cause notices to 17 Pharma manufacturers: Maharashtra
22 Pharma Firms come under GST radar
Spurious drugs worth Rs 7.3 cr seized in UP: Odisha connection
Govt soon to announce R&D policy for Pharma Sector
Spurious drugs worth Rs 2 lakh seized, distributor arrested
Duties and responsibilities of QA person in Pharma Industry
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
